Versant Vantage I GP-GP, LLC is 10% Owner at LAVA Therapeutics NV (LVTX). They have made 1 open-market trade across 1 company since 2025, most recently 2025-09-18.
CIK 0001777653
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LVTX | SELL | 2025-09-16 | 2025-09-18 | $1.48 | $5.0M | +4.7% | +0.0% | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.